Cargando…

Enhanced recovery after surgery in primary liver cancer patients undergoing hepatectomy: experience from a large tertiary hospital in China

OBJECTIVE: Enhanced recovery after surgery (ERAS) has significant effects in gastrointestinal surgery, urology, and orthopedic department, but the application of ERAS in liver cancer patients undergoing hepatectomy is less reported. This study aims to identify the effectiveness and safety of ERAS in...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Huan, Zhou, Ping, Li, Jia, Luo, Hongping, Yu, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311806/
https://www.ncbi.nlm.nih.gov/pubmed/37386393
http://dx.doi.org/10.1186/s12893-023-02040-4
_version_ 1785066819415965696
author Huang, Huan
Zhou, Ping
Li, Jia
Luo, Hongping
Yu, Liping
author_facet Huang, Huan
Zhou, Ping
Li, Jia
Luo, Hongping
Yu, Liping
author_sort Huang, Huan
collection PubMed
description OBJECTIVE: Enhanced recovery after surgery (ERAS) has significant effects in gastrointestinal surgery, urology, and orthopedic department, but the application of ERAS in liver cancer patients undergoing hepatectomy is less reported. This study aims to identify the effectiveness and safety of ERAS in liver cancer patients undergoing hepatectomy. METHODS: Patients who performed ERAS and no-ERAS after hepatectomy due to liver cancer from 2019 to 2022 were prospectively and retrospectively collected, respectively. Preoperative baseline data, surgical characteristics, and postoperative outcomes of patients in ERAS and non-ERAS groups were compared and analyzed. Logistic regression analysis was conducted to identify the risk factors of complications occurrence and prolonged hospital stay. RESULTS: In total, 318 patients were included in the study, 150 and 168 individuals in the ERAS group and non-ERAS group, respectively. The preoperative baseline and surgical characteristics between the ERAS and non-ERAS groups were comparable and not statistically different. Postoperative visual analogue scale pain score, the median day of gastrointestinal function recovery postoperative, complications rate, and postoperative hospitalization days were lower in the ERAS group than in the non-ERAS group. In addition, multivariate logistic regression analysis found that the implementation of the ERAS was an independent protective factor for prolonged hospitalization stay and complications occurrence. The rate of rehospitalization after discharge (< 30 days) in the ERAS group was lower than that in the non-ERAS group, but there was no statistical difference between the two groups. CONCLUSIONS: The application of ERAS in hepatectomy for patients with liver cancer is safe and effective. It can accelerate gastrointestinal function recovery postoperative, shorten the length of hospital stay, and reduce postoperative pain and complications. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-023-02040-4.
format Online
Article
Text
id pubmed-10311806
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103118062023-07-01 Enhanced recovery after surgery in primary liver cancer patients undergoing hepatectomy: experience from a large tertiary hospital in China Huang, Huan Zhou, Ping Li, Jia Luo, Hongping Yu, Liping BMC Surg Research OBJECTIVE: Enhanced recovery after surgery (ERAS) has significant effects in gastrointestinal surgery, urology, and orthopedic department, but the application of ERAS in liver cancer patients undergoing hepatectomy is less reported. This study aims to identify the effectiveness and safety of ERAS in liver cancer patients undergoing hepatectomy. METHODS: Patients who performed ERAS and no-ERAS after hepatectomy due to liver cancer from 2019 to 2022 were prospectively and retrospectively collected, respectively. Preoperative baseline data, surgical characteristics, and postoperative outcomes of patients in ERAS and non-ERAS groups were compared and analyzed. Logistic regression analysis was conducted to identify the risk factors of complications occurrence and prolonged hospital stay. RESULTS: In total, 318 patients were included in the study, 150 and 168 individuals in the ERAS group and non-ERAS group, respectively. The preoperative baseline and surgical characteristics between the ERAS and non-ERAS groups were comparable and not statistically different. Postoperative visual analogue scale pain score, the median day of gastrointestinal function recovery postoperative, complications rate, and postoperative hospitalization days were lower in the ERAS group than in the non-ERAS group. In addition, multivariate logistic regression analysis found that the implementation of the ERAS was an independent protective factor for prolonged hospitalization stay and complications occurrence. The rate of rehospitalization after discharge (< 30 days) in the ERAS group was lower than that in the non-ERAS group, but there was no statistical difference between the two groups. CONCLUSIONS: The application of ERAS in hepatectomy for patients with liver cancer is safe and effective. It can accelerate gastrointestinal function recovery postoperative, shorten the length of hospital stay, and reduce postoperative pain and complications. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-023-02040-4. BioMed Central 2023-06-29 /pmc/articles/PMC10311806/ /pubmed/37386393 http://dx.doi.org/10.1186/s12893-023-02040-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Huang, Huan
Zhou, Ping
Li, Jia
Luo, Hongping
Yu, Liping
Enhanced recovery after surgery in primary liver cancer patients undergoing hepatectomy: experience from a large tertiary hospital in China
title Enhanced recovery after surgery in primary liver cancer patients undergoing hepatectomy: experience from a large tertiary hospital in China
title_full Enhanced recovery after surgery in primary liver cancer patients undergoing hepatectomy: experience from a large tertiary hospital in China
title_fullStr Enhanced recovery after surgery in primary liver cancer patients undergoing hepatectomy: experience from a large tertiary hospital in China
title_full_unstemmed Enhanced recovery after surgery in primary liver cancer patients undergoing hepatectomy: experience from a large tertiary hospital in China
title_short Enhanced recovery after surgery in primary liver cancer patients undergoing hepatectomy: experience from a large tertiary hospital in China
title_sort enhanced recovery after surgery in primary liver cancer patients undergoing hepatectomy: experience from a large tertiary hospital in china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311806/
https://www.ncbi.nlm.nih.gov/pubmed/37386393
http://dx.doi.org/10.1186/s12893-023-02040-4
work_keys_str_mv AT huanghuan enhancedrecoveryaftersurgeryinprimarylivercancerpatientsundergoinghepatectomyexperiencefromalargetertiaryhospitalinchina
AT zhouping enhancedrecoveryaftersurgeryinprimarylivercancerpatientsundergoinghepatectomyexperiencefromalargetertiaryhospitalinchina
AT lijia enhancedrecoveryaftersurgeryinprimarylivercancerpatientsundergoinghepatectomyexperiencefromalargetertiaryhospitalinchina
AT luohongping enhancedrecoveryaftersurgeryinprimarylivercancerpatientsundergoinghepatectomyexperiencefromalargetertiaryhospitalinchina
AT yuliping enhancedrecoveryaftersurgeryinprimarylivercancerpatientsundergoinghepatectomyexperiencefromalargetertiaryhospitalinchina